iScience (Feb 2024)

A novel macrolide–Del-1 axis to regenerate bone in old age

  • Kridtapat Sirisereephap,
  • Hikaru Tamura,
  • Jong-Hyung Lim,
  • Meircurius Dwi Condro Surboyo,
  • Toshihito Isono,
  • Takumi Hiyoshi,
  • Andrea L. Rosenkranz,
  • Yurie Sato-Yamada,
  • Hisanori Domon,
  • Akari Ikeda,
  • Tomoyasu Hirose,
  • Toshiaki Sunazuka,
  • Nagako Yoshiba,
  • Hiroyuki Okada,
  • Yutaka Terao,
  • Takeyasu Maeda,
  • Koichi Tabeta,
  • Triantafyllos Chavakis,
  • George Hajishengallis,
  • Tomoki Maekawa

Journal volume & issue
Vol. 27, no. 2
p. 108798

Abstract

Read online

Summary: Aging is associated with increased susceptibility to chronic inflammatory bone loss disorders, such as periodontitis, in large part due to the impaired regenerative potential of aging tissues. DEL-1 exerts osteogenic activity and promotes bone regeneration. However, DEL-1 expression declines with age. Here we show that systemically administered macrolide antibiotics and a non-antibiotic erythromycin derivative, EM-523, restore DEL-1 expression in 18-month-old (“aged”) mice while promoting regeneration of bone lost due to naturally occurring age-related periodontitis. These compounds failed to induce bone regeneration in age-matched DEL-1-deficient mice. Consequently, these drugs promoted DEL-1-dependent functions, including alkaline phosphatase activity and osteogenic gene expression in the periodontal tissue while inhibiting osteoclastogenesis, leading to net bone growth. Macrolide-treated aged mice exhibited increased skeletal bone mass, suggesting that this treatment may be pertinent to systemic bone loss disorders. In conclusion, we identified a macrolide–DEL-1 axis that can regenerate bone lost due to aging-related disease.

Keywords